Articles Tagged With: HIV
-
Beliefs About Women’s Virtue and Chastity May Play a Role in Latina Risk Behaviors
The authors of a recent study revealed that endorsement of certain marianismo beliefs, related to women acting virtuous and chaste, may promote abstinence, but also are associated with sexual risk behaviors.
-
HIV Needlestick: Low Risk, High Anxiety
Worst-case scenario: a healthcare worker experiences a needlestick and is exposed to the blood of an HIV-positive patient. All things considered, there is a less than 1% chance that the healthcare worker will acquire HIV from a known positive needlestick. Despite those odds, many healthcare workers do not feel particularly lucky right after a needlestick.
-
Patients with HIV Support Clinic-Based Contraceptive Care by Pharmacists
New research shows that women with HIV infection and who happen to be high users of contraception support receiving contraception prescriptions from pharmacists.
-
Adjunctive Dexamethasone Is Not Beneficial for HIV Patients with Tuberculous Meningitis
A randomized, placebo-controlled clinical trial in human immunodeficiency virus-positive adults with tuberculous meningitis found no benefit for adjunctive dexamethasone in survival or risk of neurologic immune reconstitution inflammatory syndrome (IRIS). Side effects were similar to placebo.
-
Superinfection of Hepatitis B and Hepatitis D on the Horizon
Called a satellite virus, hepatitis delta virus (HDV) is making an outsized impact on liver disease and cancer worldwide. HDV only appears alongside a hepatitis B infection, and people living with HIV infection are particularly at risk of the disease.
-
Major Cardiovascular Event Risk Reduction with Pitavastatin in Patients Living with HIV
Among participants living with HIV who are at low-to-moderate risk for cardiovascular disease, those who received pitavastatin were 35% less likely to experience a major adverse cardiovascular event over a follow-up of approximately five years vs. those who received placebo.
-
Major Cardiovascular Event Risk Reduction with Pitavastatin in People Living with HIV
A large randomized, controlled trial (REPRIEVE) conducted by Grinspoon and colleagues showed that in participants living with human immunodeficiency virus (HIV) who are at low-to-moderate risk for cardiovascular disease, those who received pitavastatin had a 35% lower risk of experiencing a major adverse cardiovascular event over a follow-up of approximately five years than those who received placebo.
-
Long-Term Successful Virological Suppression with Dolutegravir Monotherapy in the EARL-SIMPLIFIED Trial
Dolutegravir monotherapy was demonstrated to be non-inferior as compared with combination antiretroviral therapy in EARLY-SIMPLIFIED, a randomized, controlled trial with long-term follow-up that included a highly selected group of people with HIV-1 infection.
-
Infectious Disease Alert Updates
Head and Neck Cancer Worse in HIV; Syphilis RPR May Fluctuate Before Treatment
-
Teens Benefited from Internet-Delivered Program to Prevent STIs and Pregnancy
Researchers designed an intervention to help prevent STIs and unintended pregnancy among Black teenagers in Louisiana. They found the internet-based program was well-received by the young women, and increased STI prevention behaviors.